Work

Editorial Commentary: Should “heterogeneous response” be considered as new category for assessing treatment response in patients with breast cancer?

Year: 2024

Type: editorial

Source: European Journal of Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s00259-024-07042-9

Authors: Sofia C. Vaz, David Groheux, Thiemo van Nijnatten, Lidija Antunovic, Fatima Cardoso, Felix Mottaghy, Maria Joao Cardoso, Christopher Riedl, Lioe-Fee de Geus-Oei, Gary A. Ulaner

Institutions: Champalimaud Foundation, Leiden University Medical Center, Inserm, Hôpital Saint-Louis, Université Paris Diderot, HIPI - Immunologie humaine, physiopathologie et immunithérapie, Maastricht University Medical Centre, Maastricht University, IRCCS Ospedale San Raffaele, Centro Champalimaud, Universitätsklinikum Aachen, RWTH Aachen University, Universidade Nova de Lisboa, University of Twente, Delft University of Technology, University of Southern California, Hoag Memorial Hospital Presbyterian

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4405627194

Cites: 35

Cited by: 4

Related to: 10